48,475
edits
Difference between revisions of "Electrodesiccation and curettage"
Jump to navigation
Jump to search
Electrodesiccation and curettage (view source)
Revision as of 16:35, 20 December 2023
, 16:35, 20 December 2023no edit summary
| (7 intermediate revisions by the same user not shown) | |||
| Line 1: | Line 1: | ||
'''Electrodesiccation and curettage''', abbreviated '''EDC''' and '''E+C''', is a procedure in which: | '''Electrodesiccation and curettage''', abbreviated '''EDC''' and '''E+C''', is a procedure in which: | ||
# The lesion is cut-off. | # The lesion is cut-off (sent to pathology). | ||
# The surgical site is cauterized using electricity (electrodesiccation). | # The surgical site is cauterized using electricity (electrodesiccation). | ||
# The electrodesiccated tissue is scrapped off (curettage). | # The electrodesiccated tissue is scrapped off (curettage). | ||
==General== | ==General== | ||
* | *EDCs are typically done by family physicians and dermatologists for non-[[melanoma]] skin cancers.<ref name=pmid12170889>{{Cite journal | last1 = Goldman | first1 = G. | title = The current status of curettage and electrodesiccation. | journal = Dermatol Clin | volume = 20 | issue = 3 | pages = 569-78, ix | month = Jul | year = 2002 | doi = | PMID = 12170889 }}</ref> | ||
*The practise is not without controversy.<ref name=pmid12170889/><ref name=pmid20677531>{{Cite journal | last1 = Reschly | first1 = MJ. | last2 = Shenefelt | first2 = PD. | title = Controversies in skin surgery: electrodessication and curettage versus excision for low-risk, small, well-differentiated squamous cell carcinomas. | journal = J Drugs Dermatol | volume = 9 | issue = 7 | pages = 773-6 | month = Jul | year = 2010 | doi = | PMID = 20677531 }}</ref> | *The practise is not without controversy.<ref name=pmid12170889/><ref name=pmid20677531>{{Cite journal | last1 = Reschly | first1 = MJ. | last2 = Shenefelt | first2 = PD. | title = Controversies in skin surgery: electrodessication and curettage versus excision for low-risk, small, well-differentiated squamous cell carcinomas. | journal = J Drugs Dermatol | volume = 9 | issue = 7 | pages = 773-6 | month = Jul | year = 2010 | doi = | PMID = 20677531 }}</ref> | ||
| Line 11: | Line 11: | ||
*The [[margin status]] is assessed clinically. | *The [[margin status]] is assessed clinically. | ||
**The [[pathologist]] cannot comment on whether the margin is clear or the [[surgical clearance]]. | **The [[pathologist]] cannot comment on whether the margin is clear or the [[surgical clearance]]. | ||
* | *The size of the lesion is usually impossible to determine on pathology. | ||
==Sign out== | |||
<pre> | |||
Skin, Right Shoulder, Biopsy with Curettage and Electrodesiccation (CED): | |||
- BASAL CELL CARCINOMA, margin status assessed clinically during CED. | |||
</pre> | |||
<pre> | |||
Right Upper Lip, Biopsy with Curettage and Electrodesiccation (C+E): | |||
- INVASIVE SQUAMOUS CELL CARCINOMA (well-differentiated), margin status assessed clinically during C+E. | |||
</pre> | |||
<pre> | |||
Skin Lesion, Right Midline Back, Curettage and Electrodesiccation (C&E): | |||
- BASAL CELL CARCINOMA, margin status assessed clinically during C&E. | |||
</pre> | |||
==References== | ==References== | ||